Up 22% in 2017, is the National Veterinary Care Ltd share price a buy?

The National Veterinary Care Ltd (ASX: NVL) share price has grown by 22% in 2017, it could be one of the best small caps to own. As investors, we’re always looking out for the next great investment. It’s unlikely to come from the large cap space because they’re already known by the market.

The best new ideas are likely going to come from newly-listed shares or smaller businesses, preferably both.

National Veterinary Care could be one of the best small caps to own over the next few years for the following reasons:

Defensive industry

Pets are a very important part of a lot of households. To some, a cat or a dog is a furry child. Pet owners would do almost whatever it takes to look after their pet whether the economy is going great or not.

You could almost think of vet clinics as private hospitals for pets.

Potential growth

National Vet Care is a fairly new entity having only been listed since August 2015. It started with minimal clinics and has now grown its total number to 55 with its latest acquisitions.

The share price has grown by 117% since it listed, but I think there could be a lot more to come.

At 31 December 2016 Greencross Limited (ASX: GXL) had 169 clinics, with plenty of room to grow. National Vet Care could easily grow its network in the medium term to at least two thirds of the Greencross total, which would be around 110 – double the current amount.

This potential growth should not only grow revenue nicely, but economies of scale efficiencies should start to be seen whilst the business gets bigger.

No retail business

Greencross has a great strategy of co-locating vets inside its retail businesses which should boost profitability and the new rewards system should encourage customers to use both services.

However, it is quite conceivable to imagine internet shopping may offer a competitor to Petbarn at some point in the future which could hurt its market share and/or profit margins for Greencross.

National Vet Care doesn’t face this problem as management have committed to staying as a veterinary-only business to truly take advantage of the growth of the pet market without the risk of retail.

Foolish takeaway

I think National Veterinary Care could provide shareholders with a lot of capital growth over the next few years at the current price as it expands its network. It’s currently trading at 26x FY17’s estimated earnings and doesn’t currently pay a dividend, however management expect to commence a dividend at its annual results later this year.

This isn't the only great opportunity on the market, you should check out these growth shares that could also smash the market.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Greencross Limited and NATVETCARE FPO. The Motley Fool Australia owns shares of Greencross Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.